+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders



The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders



Journal of Autoimmune Diseases 4: 3



We conducted a study in order to determine the usefulness and diagnostic value of International Autoimmune Hepatitis Group (IAHG) score in non-autoimmune hepatitis (AIH) hepatic disorders as well as in AIH/overlap syndromes and in cases with coexistence of AIH and other liver diseases. We applied the IAHG score in 423 patients with liver diseases excluding patients with AIH, AIH/overlap syndromes and AIH with concurrent other liver disease namely, patients with chronic hepatitis B (n = 109), chronic hepatitis C (n = 95), chronic hepatitis D (n = 4), alchoholic liver disease (n = 28), non-alcoholic fatty liver disease (n = 55), autoimmune cholestatic liver diseases (n = 77), liver disorders of undefined origin (n = 32) and with miscellaneous hepatic disorders (n = 23). 24 patients with AIH associated with any kind of liver disorder including 10 patients with AIH/overlap syndromes and 14 AIH with concurrent other liver disease were also investigated. 43 patients with AIH consisted the control group. The specificity of the score was 98.1% while the sensitivity in unmasking AIH in patients with either AIH/overlap syndromes or AIH with concurrent other liver diseases was only 50% and 78.6%. In the binary logistic regression model, the presence of other autoimmune diseases (p < 0.001), the total histological score (p < 0.001) and positivity for autoantibodies (p < 0.05) were identified as independent predictors for the presnce of AIH/ovea syndromes o AI with concurren other liver diseass. The IAHG scoring system has very good specificity for excluding AIH in patients with chronic liver diseases but not that sensitivity in order to unmask AIH/overlap syndromes or AIH with concurrent other liver diseases. The presence of other autoimmune diseases or autoantibody markers in the absence of hepatitis viral markers should alarm physicians for the possible presence of AIH either as "pure" AIH or in association with other liver disorders (AIH/overlap syndromes or AIH with concurrent other liver diseases). Under these conditions, liver histology seems essential and it must always be included in the work up of hepatic patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 056466727

Download citation: RISBibTeXText

PMID: 17603886

DOI: 10.1186/1740-2557-4-3


Related references

Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis. Hepato-Gastroenterology 57(99-100): 441-446, 2010

Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases. Expert Review of Gastroenterology and Hepatology 1(2): 329-340, 2009

"Overlap" syndromes. Autoimmune hepatitis--primary biliary liver cirrhosis; autoimmune hepatitis--primary sclerosing cholangitis. Presse Medicale 30(1): 25-27, 2001

Living donor liver transplantation for autoimmune hepatitis and autoimmune hepatitis-primary biliary cirrhosis overlap syndrome. 2012

The relationships between international autoimmune hepatitis score, liver histology and laboratory data in patients with chronic hepatitis C. Central-European Journal of Immunology 22(3): 194, 1997

Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?. Journal of Gastroenterology 40(12): 1130-1138, 2005

Application of the international autoimmune hepatitis group scoring system to autoimmune hepatitis and chronic hepatitis C patients. Gastroenterology 108(4 SUPPL ): A1200, 1995

Autoimmune hepatitis Clinical spectrum of disease defined by revised international autoimmune hepatitis group scoring system. Journal of Hepatology 36(Supplement 1): 261, 2002

Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group. Internal Medicine 39(12): 1008-1012, 2001

Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis. Oncotarget 9(14): 11631-11637, 2018

Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International Autoimmune Hepatitis Group. Digestive Diseases and Sciences 51(11): 1978-1984, 2006

Autoimmune Hepatitis Overlap Syndromes and Liver Pathology. Gastroenterology Clinics of North America 46(2): 345-364, 2018

Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroenterologie Clinique et Biologique 31(1): 17-25, 2007

Autoimmune liver disease (primary biliary cholangitis/autoimmune hepatitis-overlap) associated with sarcoidosis (clinical cases and literature review). Terapevticheskii Arkhiv 91(1): 89-94, 2019

A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Hepato-Gastroenterology 44(14): 417-425, 1997